trial · primary record
JNJ-80948543
Lymphoma, Non-Hodgkin
| Phase | Phase 1 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 19 |
| Primary completion | 2027-03-31 |
| Primary endpoint | Number of Participants with Dose-limiting Toxicity (DLT) |
| Registry ID | NCT06660563 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:55:47.525Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06660563
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.